Nimotuzumab plus chemoradiotherapy versus placebo plus chemoradiotherapy in patients with locally advanced nasopharyngeal carcinoma (NPC): A prospective, randomized-controlled, double-blinded, multicenter phase III clinical trial.
文献类型：期刊论文
| 作者 | Sun, Yan; Hu, Chaosu; Lin, Qin; Gao, Li; Wang, Jianhua; Zhu, Xiaodong; Hao, Junfang; Lang, Jin Yi; Wang, Peiguo; Ye, Ming |
| 刊名 | JOURNAL OF CLINICAL ONCOLOGY
 |
| 出版日期 | 2022-06-01 |
| 卷号 | 40 |
| ISSN号 | 0732-183X |
| WOS研究方向 | Oncology |
| 语种 | 英语 |
| WOS记录号 | WOS:000863680301700 |
| 出版者 | LIPPINCOTT WILLIAMS & WILKINS |
| 源URL | [http://ir.hfcas.ac.cn:8080/handle/334002/129933]  |
| 专题 | 中国科学院合肥物质科学研究院 |
| 作者单位 | 1.Liaoning Canc Hosp & Inst, Shenyang, Peoples R China 2.China Med Univ, Dept Oncol, Shengjing Hosp, Shenyang, Peoples R China 3.Hebei Med Univ, Dept Radiat Oncol, Hosp 4, Shijiazhuang, Peoples R China 4.Peking Union Med Coll Hosp, Chinese Acad Med Sci, Beijing, Peoples R China 5.Hubei Canc Hosp, Wuhan, Peoples R China 6.Fujian Med Univ, Union Hosp, Fuzhou, Peoples R China 7.Fujian Canc Hosp, Fuzhou, Peoples R China 8.Huazhong Univ Sci & Technol, Wuhan, Peoples R China 9.Shanghai Jiao Tong Univ, Renji Hosp, Sch Med, Shanghai, Peoples R China 10.Shandong Canc Hosp, Jinan, Peoples R China |
| 推荐引用方式 GB/T 7714 | Sun, Yan,Hu, Chaosu,Lin, Qin,et al. Nimotuzumab plus chemoradiotherapy versus placebo plus chemoradiotherapy in patients with locally advanced nasopharyngeal carcinoma (NPC): A prospective, randomized-controlled, double-blinded, multicenter phase III clinical trial.[J]. JOURNAL OF CLINICAL ONCOLOGY,2022,40. |
| APA | Sun, Yan.,Hu, Chaosu.,Lin, Qin.,Gao, Li.,Wang, Jianhua.,...&Pan, Jian-Ji.(2022).Nimotuzumab plus chemoradiotherapy versus placebo plus chemoradiotherapy in patients with locally advanced nasopharyngeal carcinoma (NPC): A prospective, randomized-controlled, double-blinded, multicenter phase III clinical trial..JOURNAL OF CLINICAL ONCOLOGY,40. |
| MLA | Sun, Yan,et al."Nimotuzumab plus chemoradiotherapy versus placebo plus chemoradiotherapy in patients with locally advanced nasopharyngeal carcinoma (NPC): A prospective, randomized-controlled, double-blinded, multicenter phase III clinical trial.".JOURNAL OF CLINICAL ONCOLOGY 40(2022). |
入库方式： OAI收割
来源：合肥物质科学研究院
浏览0
下载0
收藏0
其他版本
除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。